JMP Life Sciences

On-Demand Webcast

State-of-the-Art Strategies for Clinical Trial Monitoring

State of the Art Strategies for Clinical Trial Monitoring

Watch this on-demand webcast and learn how to modernize your medical and statistical clinical trial monitoring with the newly released JMP® Clinical 6.0.  

Richard Zink, PhD, and Geoffrey Mann, PhD, demonstrate how to augment your on-site clinical trial monitoring by using the latest methods in risk-based monitoring, central statistical monitoring, clinical oversight monitoring and data quality improvement available in JMP Clinical. These methods will improve and align your monitoring process with approaches that follow the recent guidance documents on risk-based monitoring created by the FDA and EMA, as well as help you identify the source of data quality issues and reduce trial costs.

This webcast addresses:

  • Risk-based monitoring that closely aligns risk indicators, thresholds and actions set forth by the TransCelerate methodology documents.
  • Central statistical monitoring methods.
  • Data quality and fraud detection methods that illustrate how to identify outlying patients and sites in a clinical trial.

The newly released JMP Clinical 6.0 emphasizes ease of use and enterprise deployment with simplified safety and efficacy reviews, and a streamlined user interface that lets JMP Clinical drastically reduce the time required to review your clinical trial data.

The speakers demonstrate the new and expanded core capabilities of JMP Clinical, including:

  • Data integrity.
  • Risk-based monitoring.
  • Medical monitoring.
  • Adverse event narratives.
  • Patient recruitment.

This webcast will be of interest to both prospective and seasoned users of JMP Clinical, from those exploring new ways to streamline their clinical trial monitoring practices to current JMP Clinical users curious about the new features and functionality of JMP Clinical 6.0.

Register now for this free Webcast.

*
*
*
*
 
  Keep me up to date with news about software updates and other information of interest to JMP users.
 
 

Back to Top